Efficacy of SYR-472 in Subjects With Type 2 Diabetes Mellitus
Public ClinicalTrials.gov record NCT00653185. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate Weekly Treatment With SYR-472 in Subjects With Type 2 Diabetes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the efficacy, safety and tolerability of SYR-472, once daily (QD), in subjects with Type 2 Diabetes Mellitus.
Study identification
- NCT ID
- NCT00653185
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 369 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2007 (Type not available)
- Primary completion
- Mar 2008 (Actual)
- Completion
- Mar 2008 (Actual)
- Last update posted
- Jun 22, 2016
2007 – 2008
United States locations
- U.S. sites
- 51
- U.S. states
- 25
- U.S. cities
- 51
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | — | — |
| Not listed | Mobile | Alabama | — | — |
| Not listed | Montgomery | Alabama | — | — |
| Not listed | Pell City | Alabama | — | — |
| Not listed | Tallassee | Alabama | — | — |
| Not listed | Sierra Vista | Arizona | — | — |
| Not listed | Fountain Valley | California | — | — |
| Not listed | Los Angeles | California | — | — |
| Not listed | National City | California | — | — |
| Not listed | Pismo Beach | California | — | — |
| Not listed | Clearwater | Florida | — | — |
| Not listed | North Miami Beach | Florida | — | — |
| Not listed | Ocoee | Florida | — | — |
| Not listed | Orlando | Florida | — | — |
| Not listed | Plantation | Florida | — | — |
| Not listed | Dawsonville | Georgia | — | — |
| Not listed | Gainesville | Georgia | — | — |
| Not listed | Naperville | Illinois | — | — |
| Not listed | Elkhart | Indiana | — | — |
| Not listed | Indianapolis | Indiana | — | — |
| Not listed | Slidell | Louisiana | — | — |
| Not listed | Taunton | Massachusetts | — | — |
| Not listed | Ann Arbor | Michigan | — | — |
| Not listed | Great Falls | Montana | — | — |
| Not listed | Scottsbluff | Nebraska | — | — |
| Not listed | Las Vegas | Nevada | — | — |
| Not listed | Brooklyn | New York | — | — |
| Not listed | Charlotte | North Carolina | — | — |
| Not listed | Shelby | North Carolina | — | — |
| Not listed | Sparta | North Carolina | — | — |
| Not listed | Fargo | North Dakota | — | — |
| Not listed | Bensalem | Ohio | — | — |
| Not listed | Dayton | Ohio | — | — |
| Not listed | Kettering | Ohio | — | — |
| Not listed | Central Point | Oregon | — | — |
| Not listed | Altoona | Pennsylvania | — | — |
| Not listed | Providence | Rhode Island | — | — |
| Not listed | Clemson | South Carolina | — | — |
| Not listed | Columbia | South Carolina | — | — |
| Not listed | Greer | South Carolina | — | — |
| Not listed | Rapid City | South Dakota | — | — |
| Not listed | Cleveland | Tennessee | — | — |
| Not listed | Kingsport | Tennessee | — | — |
| Not listed | Arlington | Texas | — | — |
| Not listed | Fort Worth | Texas | — | — |
| Not listed | North Richland Hills | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Spring | Texas | — | — |
| Not listed | Sugarland | Texas | — | — |
| Not listed | Hampton | Virginia | — | — |
| Not listed | Richmond | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 36 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00653185, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 22, 2016 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00653185 live on ClinicalTrials.gov.